Who Is Funding the Science That's Too Early for Venture Capital?
April 22, 2026
Fox Chase Cancer Center
#39 in Institutes and Centers
39Institution Overview
Overall
Ranking
39
10
Rank in
Research Capabilities
46
Rank in
Entrepreneurial Readiness
34
Rank in
Market Translation
Philadelphia, PA
Fox Chase Cancer Center, based in Philadelphia, Pennsylvania, ranks 39th among the 60 biomedical institutes assessed by the Cure Innovation Index. Its research capabilities rank 10th in the category, reflecting a profile built around scientific investigation. Market translation and entrepreneurial readiness sit considerably lower, a pattern typical of institutes that emphasize discovery over commercialization. Faculty participate actively in clinical trials as principal investigators, grounding the center's work in patient-oriented research. As a cancer center, Fox Chase carries its comparative strength in the scientific foundations of the innovation pipeline.
Ranking Metrics
Research Capabilities
Fox Chase Cancer Center ranked above average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, Fox Chase Cancer Center fared best in Cutting Edge Science.
Learn MoreEntrepreneurial Readiness
Fox Chase Cancer Center ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, Fox Chase Cancer Center fared best in Ecosystem Support.
Learn MoreMarket Translation
Fox Chase Cancer Center ranked below average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, Fox Chase Cancer Center fared best in Industry Connections.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
